Bob van de Water
Professor
- Name
- Prof. dr. B. van de Water
- Telephone
- 071 5276223
- water_b@lacdr.leidenuniv.nl
- ORCID iD
- 0000-0002-5839-2380
Prof. Dr. Bob van de Water is head of the Cancer Therapeutics and Drug Safety group at the Division of Drug Discovery & Safety.
More information about Bob van de Water
PhD Candidates
News
-
Luijten appointed as Professor of Human-Relevant Risk Assessment of Chemical Substances -
700,000 euros for the fight against aggressive breast cancer -
LACDR EMA Lunchtalk -
Safety testing of chemicals without laboratory animals -
RISK-HUNT3R: largest toxicological research project in Europe -
NWO grant for research facility into the impact of environmental factors on health -
Animal-free chemical safety testing with new technology ToxProfiler -
Assessing the safety of chemicals and medicines without laboratory animals -
Joost Beltman and Bob van de Water receive ZonMW/BMBF grant -
University invests extra funds in groundbreaking research -
The Cell Observatory just got upgraded, and here is why -
Nanoparticles: a wonder material with a downside? -
Ratification of High Troughput Microscopy Dutch Flagship Node as Euro-BioImaging Node Candidate
-
Horizon2020 grant for toxicologist Bob van de Water -
Drug development: how can we make it more efficient? -
Leiden researchers discover genes that affect spread of breast cancer
Former PhD candidates
-
Olivier Béquignon -
Muriel Heldring
-
Marije Niemeijer
-
Lukas Wijaya
-
Luc Bischoff
-
Richard Beck
-
Jichao He
-
Ronan McLaughlin
-
Thijmen Booij
-
Suzanna Huppelschoten
-
Michiel Fokkelman
-
Zuzanna Baranski Madrigal
-
Steven Hiemstra
-
Hayri Balcıoğlu
-
Steven Wink
-
Sebastiaan ter Braak
-
Sreenivasa Ramaiahgari
-
Marja Driessen
-
Zi Di
-
Veerander Ghotra
-
Louise von Stechow
-
Giulia Benedetti
-
Whilhelmina van Roosmalen
-
Lisa Frederiksson
-
Yu Qin
-
Sarah Verkoeijen
-
Jordi Carreras Puigvert
-
Hoa Truong
-
Sylvia Le Dévédec
-
Martine van Miltenburg
-
Maria ban Nimwegen
-
Yafeng Ma
-
Marjo de Graauw
Projects
- Oncogenic protein tyrosine kinases and Annexin family members in breast cancer formation and metastasis
- Live cell imaging-based modelling of cellular toxicity pathways
- Identification of novel druggable targets for estrogen-receptor positive and triple negative breast cancers
- Novel Anticancer Targets for Killing Drug Resistant Triple Negative Breast Cancer
Courses
- Theme Effects of drugs III – Drug Safety Evaluation
- Signal transduction: from target discovery to therapy
- Post Doctoral Course "Cell Toxicology"
- Post-Doctoral: "Cellular Toxicology/Predictive Toxicology" - IMI-SafeSciMET Training Programme in Safety Sciences
Professor
- Faculty of Science
- LACDR
- Divisie Cell systems and Drug Safety
- ad hoc advisor drug safety
- member of advisory board
- cursus coordinator cursus Toxicologie (1 dag) en cursus Carcinogeniciteit (1 dag)
- Editorial board member
- Lid van College